Thyrocare Technologies
THYROCARE · Healthcare > Hospital & Healthcare Services · Chairman: A Velumani · MD: Dharmil Sheth · Listing date: May 10, 2016 · Employees: 1582 · Navi Mumbai · http://www.thyrocare.com

Stock Price vs Company Growth
1d
0.5%
1w
0.3%
1m
14.4%
3m
23.0%
6m
12.6%
1y
63.1%
5y
8.4%
all
9.3%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 402 0.5%
376
538
Company Overview

Sales
792 Cr
Growth: 19.2%
Profit after Tax
138 Cr
Growth: 7.8%
Small Cap
6,392 Cr
P/E: 46.4x
Industry P/E: 45.1x
Fundamentals

Sales (Cr) ₹ 792
Growth 19.2%
EBITDA 30.9%
P/S 8.1x
Dividend 2.0%
P/E 46.4x
Book Value ₹ 48.3
PEG Ratio 2.4x
ROE 21.7%
P/B 8.3x
Shareholding Pattern

Institutions
Arisaig Asia Consumer Fund Limited
6.11 %
Nippon Life India Trustee Ltd-A/C Nippon India Nifty Small Cap 250 Index Fund
3.57 %
Fundsmith Emerging Equities Trust Plc
1.46 %
Promoters
Dr.A.Velumani
28.02 %
Thyrocare Publications Llp
12.36 %
Thyrocare Properties And Infrastructure Private Imited
9.88 %
A.Sundararaju Huf
4.57 %
Sumathi Infra Project Llp
2.98 %
Others
Bakak Financial Securities
2.84 %
Llp
0.13 %
Increase    Decrease    No change
Company Profile Detailed

Thyrocare Technologies is an India-based healthcare service provider. The Company operates with a centralized processing laboratory (CPL) in Mumbai, India for esoteric tests, and regional processing laboratory in metro cities of India and other parts of Asia.
Investors (90)
Followers (24)